Catalytic antisense DNA molecules targeting Egr-1 inhibit neointima formation following permanent ligation of rat common carotid arteries

Thrombosis and Haemostasis

Volumn 87, Issue 1, 2002, Pages 134-140

  Lowe, Harry C ^a   Chesterman, Colin N ^a   Khachigian, Levon M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Egr 1; Neointima; Oligonucleotide

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COMPLEMENTARY DNA; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; TRANSCRIPTION FACTOR EGR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY BLOOD FLOW; ARTERY INTIMA PROLIFERATION; ARTERY MEDIA; ARTICLE; CAROTID ARTERY LIGATION; CATALYSIS; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG INHIBITION; GENE TARGETING; IMMEDIATE EARLY GENE; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RESTENOSIS; STENT; ZINC FINGER MOTIF;

EID: 0036145716     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1612956     Document Type: Article

References (32)

1. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries
2. Dramatic increase in the use of coronary stents
3. Pathology of in-stent restenosis
4. The utility of animal models in the preclinical study of interventions to prevent human coronary artery restenosis: Analysis and recommendations
5. Histopathological reactivity of carotid arteries of normotensive spraguedawley vs spontaneously hypertensive rats to ligation injury
6. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium
7. Time course of flow-induced smooth muscle cell proliferation and intimal thickening in endothelialized baboon vascular grafts
8. Increased blood flow induces regression of intimal hyperplasia
9. Anastomotic intimal hyperplasia: Mechanical injury or flow induced
10. Strain-dependent vascular remodeling phenotypes in inbred mice
11. Remodelling with neointima formation in the mouse carotid artery after cessation of blood flow
12. Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1
13. Egr-1 is activated in endothelial cells exposed to fluid shear stress and interacts with a novel shear-stress-response element in the PDGF A-chain promoter
14. Inducible expression of Egr-1 dependent genes: A paradigm of transcriptional activation in vascular endothelium
15. Novel DNA enzyme targeting NGFI-A mRNA inhibits vascular smooth muscle proliferation and regrowth after injury
16. A microcomputer-based system for semi-automatic analysis of histological sections
17. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model
18. The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries
19. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice
20. Mechanisms of stenosis after arterial injury
21. Animal models of human coronary restenosis
22. Endothelial dysfunction, hemodynamic forces and athersclerosis
23. Blood flow and vascular gene expression: Fluid shear stress as a modulator of endothelial phenotype
24. The pathogenesis of atherosclerosis
25. The pathogenesis of atherosclerosis: A perspective for the 1990's
26. Three-dimensional intravascular ultrasound analysis of coronary stent deployment and in-stent neointimal volume: Current clinical practice and the concepts of TRAPIST, ERASER, and ITALICS
27. Experimental models of coronary artery restenosis
28. Egr-1 induction by injury is triggered by release and paracrine activation by fibroblast growth factor 2
29. Acute, local release of Fibroblast Growth Factor (FGF 2), but not Transforming Growth Factor b1 (TGF b1), following coronary stenting
30. Catalytic nucleic acids: From lab to applications
31. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia